Below is a daily summary of links to the latest SPAC news and rumors gathered across the web.
Latest SPAC News: Elizabeth Warren, other Senate Democrats raise concerns about SPAC incentives, Singapore startup Mirxes in talks to merge with Summit Healthcare, and IonQ partners with GE Research
Elizabeth Warren and Democrats Are Going After SPAC Kingpins
Elizabeth Warren and other Senate Democrats are targeting some of the biggest names behind SPACs, questioning whether the once red-hot market will trigger outsized losses for retail investors.
In letters to six prominent operators of SPACs, the lawmakers highlighted concerns that insiders can take advantage of regulatory loopholes at the expense of shareholders.
READSingapore Biotech Startup Mirxes in Talks For $1.2B SPAC Listing in US
Singapore biotech company Mirxes is in early talks to merge with Summit Healthcare Acquisition Corp. (NASDAQ:SMIH), a SPAC affiliated with veteran private equity healthcare investor Fu Wei, according to Business Times.
READIonQ and GE Research Partner to Explore How Quantum Computing Could Impact Risk Management
IonQ, Inc., a leader in quantum computing, today announced an initiative in partnership with GE Research to explore the impact of quantum computing and IonQ’s quantum computers in the pivotal field of risk analysis.
The initiative is expected to lay the groundwork for risk management across key sectors including finance, government and others.
On March 8, IonQ announced it would go public via a merger with dMY Technology Group, Inc. III (NYSE: DMYI).
READ
Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...
At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...
Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...
At the SPAC of Dawn Ever since Digital World announced its combination with Trump Media (NASDAQ:DJT) back in October 2021, it was clear that SPACworld and the Trump show were set to be intertwined for quite some time. And, although not every headline has a bearing on the wider SPAC world, Trump Media’s post-close rise...
AltC (NYSE:ALCC) has reportedly been taking the pitch deck for its combination with nuclear fission firm Oklo on the road in recent weeks, which has generated the rare result of a SPAC trading significantly above its trust value still well before completing its deal. The SPAC has an estimated $10.59 per share in its trust...